메뉴 건너뛰기




Volumn 33, Issue 32, 2014, Pages 4173-4184

The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx)

(31)  Ciarapica, R a   De Salvo, M a   Carcarino, E b   Bracaglia, G a   Adesso, L a   Leoncini, P P a   Dall'Agnese, A b   Walters, Z S c   Verginelli, F a   De Sio, L a   Boldrini, R d   Inserra, A d   Bisogno, G e   Rosolen, A e   Alaggio, R e   Ferrari, A f   Collini, P f   Locatelli, M d   Stifani, S g   Screpanti, I h   more..

a IRCCS   (Italy)

Author keywords

EZH2; FBXO32; histone methyltransferases; PAX3 FOXO1; Polycomb proteins; rhabdomyosarcoma

Indexed keywords

ADOLESCENT; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CHILD; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTONE-LYSINE N-METHYLTRANSFERASE; HOMEOSTASIS; HUMANS; MALE; MUSCLE PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; POLYCOMB REPRESSIVE COMPLEX 2; RHABDOMYOSARCOMA, ALVEOLAR; SKP CULLIN F-BOX PROTEIN LIGASES;

EID: 84905868284     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.471     Document Type: Article
Times cited : (61)

References (73)
  • 1
    • 77952299529 scopus 로고    scopus 로고
    • Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma
    • Williamson D, Missiaglia E, de Reynies A, Pierron G, Thuille B, Palenzuela G et al. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 2010; 28: 2151-2158.
    • (2010) J Clin Oncol , vol.28 , pp. 2151-2158
    • Williamson, D.1    Missiaglia, E.2    De Reynies, A.3    Pierron, G.4    Thuille, B.5    Palenzuela, G.6
  • 2
    • 84863748866 scopus 로고    scopus 로고
    • PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification
    • Missiaglia E, Williamson D, Chisholm J, Wirapati P, Pierron G, Petel F et al. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol 2012; 30: 1670-1677.
    • (2012) J Clin Oncol , vol.30 , pp. 1670-1677
    • Missiaglia, E.1    Williamson, D.2    Chisholm, J.3    Wirapati, P.4    Pierron, G.5    Petel, F.6
  • 4
    • 54549119169 scopus 로고    scopus 로고
    • NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma
    • Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008; 14: 369-381.
    • (2008) Cancer Cell , vol.14 , pp. 369-381
    • Wang, H.1    Garzon, R.2    Sun, H.3    Ladner, K.J.4    Singh, R.5    Dahlman, J.6
  • 5
    • 68849118992 scopus 로고    scopus 로고
    • The musclespecific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation
    • Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M et al. The musclespecific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 2009; 119: 2366-2378.
    • (2009) J Clin Invest , vol.119 , pp. 2366-2378
    • Taulli, R.1    Bersani, F.2    Foglizzo, V.3    Linari, A.4    Vigna, E.5    Ladanyi, M.6
  • 6
    • 84859569795 scopus 로고    scopus 로고
    • Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo
    • Raimondi L, Ciarapica R, De Salvo M, Verginelli F, Gueguen M, Martini C et al. Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo. Cell Death Differ 2012; 19: 871-881.
    • (2012) Cell Death Differ , vol.19 , pp. 871-881
    • Raimondi, L.1    Ciarapica, R.2    De Salvo, M.3    Verginelli, F.4    Gueguen, M.5    Martini, C.6
  • 7
    • 84870169122 scopus 로고    scopus 로고
    • Memories from the polycomb group proteins
    • Lanzuolo C, Orlando V. Memories from the polycomb group proteins. Annu Rev Genet 2012; 46: 561-589.
    • (2012) Annu Rev Genet , vol.46 , pp. 561-589
    • Lanzuolo, C.1    Orlando, V.2
  • 8
    • 78751662908 scopus 로고    scopus 로고
    • The Polycomb complex PRC2 and its mark in life
    • Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011; 469: 343-349.
    • (2011) Nature , vol.469 , pp. 343-349
    • Margueron, R.1    Reinberg, D.2
  • 9
    • 84876076090 scopus 로고    scopus 로고
    • Ezh2 maintains a key phase of muscle satellite cell expansion but does not regulate terminal differentiation
    • Woodhouse S, Pugazhendhi D, Brien P, Pell JM. Ezh2 maintains a key phase of muscle satellite cell expansion but does not regulate terminal differentiation. J Cell Sci 2012; 126: 565-579.
    • (2012) J Cell Sci , vol.126 , pp. 565-579
    • Woodhouse, S.1    Pugazhendhi, D.2    Brien, P.3    Pell, J.M.4
  • 10
    • 79955459714 scopus 로고    scopus 로고
    • Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells
    • Juan AH, Derfoul A, Feng X, Ryall JG, Dell'Orso S, Pasut A et al. Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells. Genes Dev 2011; 25: 789-794.
    • (2011) Genes Dev , vol.25 , pp. 789-794
    • Juan, A.H.1    Derfoul, A.2    Feng, X.3    Ryall, J.G.4    Dell'Orso, S.5    Pasut, A.6
  • 11
    • 7544230144 scopus 로고    scopus 로고
    • The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation
    • DOI 10.1101/gad.1241904
    • Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 2004; 18: 2627-2638. (Pubitemid 39453102)
    • (2004) Genes and Development , vol.18 , Issue.21 , pp. 2627-2638
    • Caretti, G.1    Di Padova, M.2    Micales, B.3    Lyons, G.E.4    Sartorelli, V.5
  • 13
    • 84856237597 scopus 로고    scopus 로고
    • Polycomb protein Ezh1 promotes RNA polymerase II elongation
    • Mousavi K, Zare H, Wang AH, Sartorelli V. Polycomb protein Ezh1 promotes RNA polymerase II elongation. Mol Cell 2012; 45: 255-262.
    • (2012) Mol Cell , vol.45 , pp. 255-262
    • Mousavi, K.1    Zare, H.2    Wang, A.H.3    Sartorelli, V.4
  • 15
    • 0142105414 scopus 로고    scopus 로고
    • EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
    • DOI 10.1093/emboj/cdg542
    • Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. Embo J 2003; 22: 5323-5335. (Pubitemid 37279943)
    • (2003) EMBO Journal , vol.22 , Issue.20 , pp. 5323-5335
    • Bracken, A.P.1    Pasini, D.2    Capra, M.3    Prosperini, E.4    Colli, E.5    Helin, K.6
  • 18
    • 77956277833 scopus 로고    scopus 로고
    • EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients
    • Rao ZY, Cai MY, Yang GF, He LR, Mai SJ, Hua WF et al. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. Carcinogenesis 2010; 31: 1576-1583.
    • (2010) Carcinogenesis , vol.31 , pp. 1576-1583
    • Rao, Z.Y.1    Cai, M.Y.2    Yang, G.F.3    He, L.R.4    Mai, S.J.5    Hua, W.F.6
  • 19
    • 84855433971 scopus 로고    scopus 로고
    • Polycomb repressor complex-2 is a novel target for mesothelioma therapy
    • Kemp CD, Rao M, Xi S, Inchauste S, Mani H, Fetsch P et al. Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Clin Cancer Res 2011; 18: 77-90.
    • (2011) Clin Cancer Res , vol.18 , pp. 77-90
    • Kemp, C.D.1    Rao, M.2    Xi, S.3    Inchauste, S.4    Mani, H.5    Fetsch, P.6
  • 22
    • 77950866779 scopus 로고    scopus 로고
    • Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression
    • Wu ZL, Zheng SS, Li ZM, Qiao YY, Aau MY, Yu Q. Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ 2010; 17: 801-810.
    • (2010) Cell Death Differ , vol.17 , pp. 801-810
    • Wu, Z.L.1    Zheng, S.S.2    Li, Z.M.3    Qiao, Y.Y.4    Aau, M.Y.5    Yu, Q.6
  • 23
    • 80053935847 scopus 로고    scopus 로고
    • Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage
    • Wu Z, Lee ST, Qiao Y, Li Z, Lee PL, Lee YJ et al. Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage. Cell Death Differ 2011; 18: 1771-1779.
    • (2011) Cell Death Differ , vol.18 , pp. 1771-1779
    • Wu, Z.1    Lee, S.T.2    Qiao, Y.3    Li, Z.4    Lee, P.L.5    Lee, Y.J.6
  • 24
    • 84855392434 scopus 로고    scopus 로고
    • EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR
    • Wang C, Liu Z, Woo CW, Li Z, Wang L, Wei JS et al. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res 2011; 72: 315-324.
    • (2011) Cancer Res , vol.72 , pp. 315-324
    • Wang, C.1    Liu, Z.2    Woo, C.W.3    Li, Z.4    Wang, L.5    Wei, J.S.6
  • 25
    • 70350494322 scopus 로고    scopus 로고
    • Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
    • Fiskus W, Wang Y, Sreekumar A, Buckley KM, Shi H, Jillella A et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood 2009; 114: 2733-2743.
    • (2009) Blood , vol.114 , pp. 2733-2743
    • Fiskus, W.1    Wang, Y.2    Sreekumar, A.3    Buckley, K.M.4    Shi, H.5    Jillella, A.6
  • 26
    • 84871841675 scopus 로고    scopus 로고
    • Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
    • Qi W, Chan H, Teng L, Li L, Chuai S, Zhang R et al. Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci USA 2012; 109: 21360-21365.
    • (2012) Proc Natl Acad Sci USA , vol.109 , pp. 21360-21365
    • Qi, W.1    Chan, H.2    Teng, L.3    Li, L.4    Chuai, S.5    Zhang, R.6
  • 28
    • 84869215617 scopus 로고    scopus 로고
    • Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells
    • Fiskus W, Rao R, Balusu R, Ganguly S, Tao J, Sotomayor E et al. Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells. Clin Cancer Res 2012; 18: 6227-6238.
    • (2012) Clin Cancer Res , vol.18 , pp. 6227-6238
    • Fiskus, W.1    Rao, R.2    Balusu, R.3    Ganguly, S.4    Tao, J.5    Sotomayor, E.6
  • 29
    • 84870573126 scopus 로고    scopus 로고
    • EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
    • McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 2012; 492: 108-112.
    • (2012) Nature , vol.492 , pp. 108-112
    • McCabe, M.T.1    Ott, H.M.2    Ganji, G.3    Korenchuk, S.4    Thompson, C.5    Van Aller, G.S.6
  • 30
    • 84896691188 scopus 로고    scopus 로고
    • JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
    • Walters ZS, Villarejo-Balcells B, Olmos D, Buist TWS, Missiaglia E, Allen R et al. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells. Oncogene 2014; 33: 1148-1157.
    • (2014) Oncogene , vol.33 , pp. 1148-1157
    • Walters, Z.S.1    Villarejo-Balcells, B.2    Olmos, D.3    Buist, T.W.S.4    Missiaglia, E.5    Allen, R.6
  • 32
    • 84868014011 scopus 로고    scopus 로고
    • The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation
    • Marchesi I, Fiorentino FP, Rizzolio F, Giordano A, Bagella L. The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation. Cell Cycle 2012; 11: 3828-3836.
    • (2012) Cell Cycle , vol.11 , pp. 3828-3836
    • Marchesi, I.1    Fiorentino, F.P.2    Rizzolio, F.3    Giordano, A.4    Bagella, L.5
  • 33
    • 41849112166 scopus 로고    scopus 로고
    • Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitors
    • Mai A, Valente S, Cheng D, Perrone A, Ragno R, Simeoni S et al. Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitors. ChemMedChem 2007; 2: 987-991.
    • (2007) Chem Med Chem , vol.2 , pp. 987-991
    • Mai, A.1    Valente, S.2    Cheng, D.3    Perrone, A.4    Ragno, R.5    Simeoni, S.6
  • 34
    • 84867395419 scopus 로고    scopus 로고
    • Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells
    • Valente S, Lepore I, Dell'Aversana C, Tardugno M, Castellano S, Sbardella G et al. Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells. Biochimie 2012; 94: 2308-2313.
    • (2012) Biochimie , vol.94 , pp. 2308-2313
    • Valente, S.1    Lepore, I.2    Dell'Aversana, C.3    Tardugno, M.4    Castellano, S.5    Sbardella, G.6
  • 35
    • 44349086037 scopus 로고    scopus 로고
    • MicroRNA-26a targets the histone methyltransferase enhancer of zeste homolog 2 during myogenesis
    • Wong CF, Tellam RL. MicroRNA-26a targets the histone methyltransferase enhancer of zeste homolog 2 during myogenesis. J Biol Chem 2008; 283: 9836-9843.
    • (2008) J Biol Chem , vol.283 , pp. 9836-9843
    • Wong, C.F.1    Tellam, R.L.2
  • 36
    • 70349764482 scopus 로고    scopus 로고
    • Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells
    • Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009; 36: 61-74.
    • (2009) Mol Cell , vol.36 , pp. 61-74
    • Juan, A.H.1    Kumar, R.M.2    Marx, J.G.3    Young, R.A.4    Sartorelli, V.5
  • 37
    • 72249104107 scopus 로고    scopus 로고
    • Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells
    • Shen X, Kim W, Fujiwara Y, Simon MD, Liu Y, Mysliwiec MR et al. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009; 139: 1303-1314.
    • (2009) Cell , vol.139 , pp. 1303-1314
    • Shen, X.1    Kim, W.2    Fujiwara, Y.3    Simon, M.D.4    Liu, Y.5    Mysliwiec, M.R.6
  • 38
    • 72249119297 scopus 로고    scopus 로고
    • Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells
    • Peng JC, Valouev A, Swigut T, Zhang J, Zhao Y, Sidow A et al. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 2009; 139: 1290-1302.
    • (2009) Cell , vol.139 , pp. 1290-1302
    • Peng, J.C.1    Valouev, A.2    Swigut, T.3    Zhang, J.4    Zhao, Y.5    Sidow, A.6
  • 41
    • 77957357566 scopus 로고    scopus 로고
    • TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration
    • Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V et al. TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010; 7: 455-469.
    • (2010) Cell Stem Cell , vol.7 , pp. 455-469
    • Palacios, D.1    Mozzetta, C.2    Consalvi, S.3    Caretti, G.4    Saccone, V.5    Proserpio, V.6
  • 42
    • 67649371461 scopus 로고    scopus 로고
    • DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
    • Miranda TB, Cortez CC, Yoo CB, Liang G, Abe M, Kelly TK et al. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol Cancer Ther 2009; 8: 1579-1588.
    • (2009) Mol Cancer Ther , vol.8 , pp. 1579-1588
    • Miranda, T.B.1    Cortez, C.C.2    Yoo, C.B.3    Liang, G.4    Abe, M.5    Kelly, T.K.6
  • 43
    • 84872568809 scopus 로고    scopus 로고
    • Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation
    • Gannon OM, Merida de Long L, Endo-Munoz L, Hazar-Rethinam M, Saunders NA. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation. Clin Cancer Res 2012; 19: 428-441.
    • (2012) Clin Cancer Res , vol.19 , pp. 428-441
    • Gannon, O.M.1    Merida De Long, L.2    Endo-Munoz, L.3    Hazar-Rethinam, M.4    Saunders, N.A.5
  • 44
    • 84871674660 scopus 로고    scopus 로고
    • Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells
    • Benoit YD, Laursen KB, Witherspoon MS, Lipkin SM, Gudas LJ. Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells. J cell physiol 2012; 228: 764-772.
    • (2012) J Cell Physiol , vol.228 , pp. 764-772
    • Benoit, Y.D.1    Laursen, K.B.2    Witherspoon, M.S.3    Lipkin, S.M.4    Gudas, L.J.5
  • 45
    • 84864458265 scopus 로고    scopus 로고
    • TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep)
    • Cheng LL, Itahana Y, Lei ZD, Chia NY, Wu Y, Yu Y et al. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin Cancer Res 2012; 18: 4201-4212.
    • (2012) Clin Cancer Res , vol.18 , pp. 4201-4212
    • Cheng, L.L.1    Itahana, Y.2    Lei, Z.D.3    Chia, N.Y.4    Wu, Y.5    Yu, Y.6
  • 47
    • 59649085853 scopus 로고    scopus 로고
    • Molecular classification of rhabdomyosarcoma-genotypic and phenotypic determinants of diagnosis: A report from the Children's Oncology Group
    • Davicioni E, Anderson MJ, Finckenstein FG, Lynch JC, Qualman SJ, Shimada H et al. Molecular classification of rhabdomyosarcoma-genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. Am J Pathol 2009; 174: 550-564.
    • (2009) Am J Pathol , vol.174 , pp. 550-564
    • Davicioni, E.1    Anderson, M.J.2    Finckenstein, F.G.3    Lynch, J.C.4    Qualman, S.J.5    Shimada, H.6
  • 48
    • 53049083206 scopus 로고    scopus 로고
    • Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations
    • Ren YX, Finckenstein FG, Abdueva DA, Shahbazian V, Chung B, Weinberg KI et al. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Cancer Res 2008; 68: 6587-6597.
    • (2008) Cancer Res , vol.68 , pp. 6587-6597
    • Ren, Y.X.1    Finckenstein, F.G.2    Abdueva, D.A.3    Shahbazian, V.4    Chung, B.5    Weinberg, K.I.6
  • 50
    • 11144356337 scopus 로고    scopus 로고
    • Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
    • DOI 10.1016/S0092-8674(04)00400-3, PII S0092867404004003
    • Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117: 399-412. (Pubitemid 38534545)
    • (2004) Cell , vol.117 , Issue.3 , pp. 399-412
    • Sandri, M.1    Sandri, C.2    Gilbert, A.3    Skurk, C.4    Calabria, E.5    Picard, A.6    Walsh, K.7    Schiaffino, S.8    Lecker, S.H.9    Goldberg, A.L.10
  • 51
    • 77955739897 scopus 로고    scopus 로고
    • Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer
    • Cao L, Yu Y, Bilke S, Walker RL, Mayeenuddin LH, Azorsa DO et al. Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res 2010; 70: 6497-6508.
    • (2010) Cancer Res , vol.70 , pp. 6497-6508
    • Cao, L.1    Yu, Y.2    Bilke, S.3    Walker, R.L.4    Mayeenuddin, L.H.5    Azorsa, D.O.6
  • 52
    • 84879523946 scopus 로고    scopus 로고
    • Opposite roles of myocardin and atrogin-1 in L6 myoblast differentiation
    • Jiang Y, Singh P, Yin H, Zhou YX, Gui Y, Wang DZ et al. Opposite roles of myocardin and atrogin-1 in L6 myoblast differentiation. J cell physiol 2013; 228: 1989-1995.
    • (2013) J Cell Physiol , vol.228 , pp. 1989-1995
    • Jiang, Y.1    Singh, P.2    Yin, H.3    Zhou, Y.X.4    Gui, Y.5    Wang, D.Z.6
  • 53
    • 63149106832 scopus 로고    scopus 로고
    • Differential cell death regulation between adult-unloaded and aged rat soleus muscle
    • Ogata T, Machida S, Oishi Y, Higuchi M, Muraoka I. Differential cell death regulation between adult-unloaded and aged rat soleus muscle. Mech ageing Dev 2009; 130: 328-336.
    • (2009) Mech Ageing Dev , vol.130 , pp. 328-336
    • Ogata, T.1    Machida, S.2    Oishi, Y.3    Higuchi, M.4    Muraoka, I.5
  • 55
    • 84860118049 scopus 로고    scopus 로고
    • Caspase-3, myogenic transcription factors and cell cycle inhibitors are regulated by leukemia inhibitory factor to mediate inhibition of myogenic differentiation
    • Hunt LC, Upadhyay A, Jazayeri JA, Tudor EM, White JD. Caspase-3, myogenic transcription factors and cell cycle inhibitors are regulated by leukemia inhibitory factor to mediate inhibition of myogenic differentiation. Skelet muscle 2011; 1: 17.
    • (2011) Skelet Muscle , vol.1 , pp. 17
    • Hunt, L.C.1    Upadhyay, A.2    Jazayeri, J.A.3    Tudor, E.M.4    White, J.D.5
  • 56
    • 77957244932 scopus 로고    scopus 로고
    • Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases
    • Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J et al. Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 2010; 143: 35-45.
    • (2010) Cell , vol.143 , pp. 35-45
    • Moresi, V.1    Williams, A.H.2    Meadows, E.3    Flynn, J.M.4    Potthoff, M.J.5    McAnally, J.6
  • 58
    • 53549089902 scopus 로고    scopus 로고
    • Decreased muscle atrophy F-box (MAFbx) expression in regenerating muscle after muscle-damaging exercise
    • Okada A, Ono Y, Nagatomi R, Kishimoto KN, Itoi E. Decreased muscle atrophy F-box (MAFbx) expression in regenerating muscle after muscle-damaging exercise. Muscle Nerve 2008; 38: 1246-1253.
    • (2008) Muscle Nerve , vol.38 , pp. 1246-1253
    • Okada, A.1    Ono, Y.2    Nagatomi, R.3    Kishimoto, K.N.4    Itoi, E.5
  • 60
    • 65549097264 scopus 로고    scopus 로고
    • Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation
    • Xie P, Guo S, Fan Y, Zhang H, Gu D, Li H. Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation. J biol chem 2009; 284: 5488-5496.
    • (2009) J Biol Chem , vol.284 , pp. 5488-5496
    • Xie, P.1    Guo, S.2    Fan, Y.3    Zhang, H.4    Gu, D.5    Li, H.6
  • 61
    • 77949903838 scopus 로고    scopus 로고
    • Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: A report from the children's oncology group
    • Davicioni E, Anderson JR, Buckley JD, Meyer WH, Triche TJ. Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group. J Clin Oncol 2010; 28: 1240-1246.
    • (2010) J Clin Oncol , vol.28 , pp. 1240-1246
    • Davicioni, E.1    Anderson, J.R.2    Buckley, J.D.3    Meyer, W.H.4    Triche, T.J.5
  • 64
    • 84863954538 scopus 로고    scopus 로고
    • FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma
    • Crose LE, Etheridge KT, Chen C, Belyea B, Talbot LJ, Bentley RC et al. FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma. Clin Cancer Res 2012; 18: 3780-3790.
    • (2012) Clin Cancer Res , vol.18 , pp. 3780-3790
    • Crose, L.E.1    Etheridge, K.T.2    Chen, C.3    Belyea, B.4    Talbot, L.J.5    Bentley, R.C.6
  • 65
    • 79957913522 scopus 로고    scopus 로고
    • Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state
    • Lee MH, Jothi M, Gudkov AV, Mal AK. Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state. Cancer Res 2011; 71: 3921-3931.
    • (2011) Cancer Res , vol.71 , pp. 3921-3931
    • Lee, M.H.1    Jothi, M.2    Gudkov, A.V.3    Mal, A.K.4
  • 66
    • 84862556419 scopus 로고    scopus 로고
    • Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation
    • Momparler RL, Idaghdour Y, Marquez VE, Momparler LF. Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation. Leuk Res 2012; 36: 1049-1054.
    • (2012) Leuk Res , vol.36 , pp. 1049-1054
    • Momparler, R.L.1    Idaghdour, Y.2    Marquez, V.E.3    Momparler, L.F.4
  • 67
    • 79953108690 scopus 로고    scopus 로고
    • Epigenetics in cancer: What's the future?
    • Boumber Y, Issa JP. Epigenetics in cancer: what's the future? Oncology 2012; 25: 220-226228.
    • (2012) Oncology , vol.25 , pp. 220-226228
    • Boumber, Y.1    Issa, J.P.2
  • 68
    • 84861134077 scopus 로고    scopus 로고
    • Epigenetic changes in pediatric solid tumors: Promising new targets
    • Lawlor ER, Thiele CJ. Epigenetic changes in pediatric solid tumors: promising new targets. Clin Cancer Res 2012; 18: 2768-2779.
    • (2012) Clin Cancer Res , vol.18 , pp. 2768-2779
    • Lawlor, E.R.1    Thiele, C.J.2
  • 69
    • 79954471872 scopus 로고    scopus 로고
    • EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression
    • Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res 2011; 9: 418-429.
    • (2011) Mol Cancer Res , vol.9 , pp. 418-429
    • Fan, T.1    Jiang, S.2    Chung, N.3    Alikhan, A.4    Ni, C.5    Lee, C.C.6
  • 70
    • 84862161257 scopus 로고    scopus 로고
    • A transcriptional repressor co-regulatory network governing androgen response in prostate cancers
    • Chng KR, Chang CW, Tan SK, Yang C, Hong SZ, Sng NY et al. A transcriptional repressor co-regulatory network governing androgen response in prostate cancers. Embo J 2012; 31: 2810-2823.
    • (2012) Embo J , vol.31 , pp. 2810-2823
    • Chng, K.R.1    Chang, C.W.2    Tan, S.K.3    Yang, C.4    Hong, S.Z.5    Sng, N.Y.6
  • 71
    • 3042763342 scopus 로고    scopus 로고
    • P38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci
    • DOI 10.1038/ng1378
    • Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat genet 2004; 36: 738-743. (Pubitemid 38886636)
    • (2004) Nature Genetics , vol.36 , Issue.7 , pp. 738-743
    • Simone, C.1    Forcales, S.V.2    Hill, D.A.3    Imbalzano, A.N.4    Latella, L.5    Puri, P.L.6
  • 72
    • 0034096583 scopus 로고    scopus 로고
    • Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor
    • DOI 10.1016/S0166-3542(00)00066-8, PII S0166354200000668
    • Bray M, Driscoll J, Huggins JW. Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor. Antiviral Res 2000; 45: 135-147. (Pubitemid 30156782)
    • (2000) Antiviral Research , vol.45 , Issue.2 , pp. 135-147
    • Bray, M.1    Driscoll, J.2    Huggins, J.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.